ROCK inhibitor-2

CAS No. 1127308-52-4

ROCK inhibitor-2( —— )

Catalog No. M23320 CAS No. 1127308-52-4

ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 97 In Stock
5MG 160 In Stock
10MG 259 In Stock
25MG 520 In Stock
50MG 750 In Stock
100MG 1035 In Stock
500MG 2061 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ROCK inhibitor-2
  • Note
    Research use only, not for human use.
  • Brief Description
    ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).
  • Description
    ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    ROCK1|ROCK2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1127308-52-4
  • Formula Weight
    332.4
  • Molecular Formula
    C21H20N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (752.11 mM; Need ultrasonic)
  • SMILES
    O=C(N[C@@H](C1=CC=CC(OC)=C1)C)C2=CC=C(C3=CC=NC=C3)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hobson AD, et al. Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based DrugDesign. J Med Chem. 2018 Dec 27;61(24):11074-11100.
molnova catalog
related products
  • Chroman 1

    Chroman 1 is a potent inhibitor of ROCK1 (IC50?= 52 pM) and ROCK2 (IC50?= 1 pM).

  • CAY10746

    CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.

  • Cotosudil

    Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.